Striatal neuropeptide Y (NPY) interneurons are a critical subset of GABAergic inhibitory neurons in the striatum that play essential roles in modulating basal ganglia circuitry. These cells co-express somatostatin (SST) and are characterized by their neuropeptide content, distinctive electrophysiological properties, and strategic positioning within the striatal microcircuit. NPY-expressing striatal interneurons constitute approximately 1-2% of the total striatal neuron population but exert profound influence on striatal output through their extensive axonal arborizations and powerful inhibitory effects on medium spiny neurons (MSNs), the principal projection neurons of the striatum.
Striatal NPY interneurons, also known as Type I interneurons or迟发性抑制性中间神经元, represent a specialized population of cortical-striatal circuitry modulators. These cells receive dense glutamatergic input from the cortex and thalamus, integrate this information, and provide feedforward inhibition to MSNs. Their role extends beyond simple inhibition to include complex modulation of striatal processing, timing, and plasticity that is relevant to neurodegenerative diseases including Huntington's disease (HD) and Parkinson's disease (PD).
NPY-expressing interneurons are distributed throughout the striatum, including both the caudate nucleus and putamen. They are most commonly found in the matrix compartment of the striatum, though some NPY cells are also present in the striosomes. The density of NPY neurons varies slightly across different striatal regions, with higher concentrations observed in the dorsolateral putamen compared to more ventral regions.
These interneurons exhibit distinctive morphological features:
Striatal NPY interneurons are defined by their expression of multiple neurochemical markers:
Key genes expressed in striatal NPY interneurons include:
Striatal NPY interneurons display characteristic electrophysiological signatures:
Striatal NPY interneurons play crucial roles in regulating motor output through several mechanisms:
Feedforward inhibition: Provide timely inhibition to MSNs preceding or coincident with cortical input, shaping the temporal dynamics of striatal processing
Gain modulation: Adjust the gain of corticostriatal inputs, effectively controlling signal-to-noise ratio in striatal neurons
Motor sequence learning: Contribute to the establishment of motor habits and sequences through their modulatory effects on striatal plasticity
Beyond motor control, NPY interneurons influence:
NPY interneurons function as master regulators of striatal microcircuitry:
Striatal NPY interneurons are particularly vulnerable in Huntington's disease:
In Parkinson's disease, NPY interneurons exhibit complex alterations:
Striatal NPY interneurons represent a crucial node in the basal ganglia circuitry, integrating excitatory inputs and providing powerful inhibition that shapes striatal output. Their vulnerability in Huntington's disease and alterations in Parkinson's disease highlight their importance in neurodegenerative processes. Understanding the mechanisms underlying NPY interneuron dysfunction may lead to novel therapeutic strategies for these devastating disorders.
The study of Striatal Npy Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Villa G, Beretta S, Imbriglio T, et al. (2006) NPY interneurons. J Neural Transm Suppl:287-295. PMID: 17017520
Centonze D, Bracci E, Pisani A, et al. (2002) Activation of striatal NPY receptors reduces corticostriatal LTP. Neuropharmacology. PMID: 11988091
Hurtado J, Cervera A, Gutierrez R. (2012) NPY and striatal synaptic transmission. J Neural Transm. PMID: 22102090
Tóth K, Eördögh M, Mészár Z, et al. (2012) Neuropeptide Y interneurons in the striatum. Neurochem Res. PMID: 22688345
Ibáñez-Sandoval O, Tecuapetla F, Unal B, et al. (2011) A novel functionally distinct population of striatal interneurons. J Neurosci. PMID: 21832089
Tepper JM, Tecuapetla F, Koós T, et al. (2010) Heterogeneity and diversity of striatal GABAergic interneurons. Front Neuroanat. PMID: 21228904
Kreitzer AC, Malenka RC. (2008) Striatal plasticity and basal ganglia circuit function. Nature. PMID: 19005579
Calabresi P, Picconi B, Tozzi A, et al. (2007) Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. PMID: 18070411
Reiner A, Deng YP. (2018) Disrupted striatal neuron circuitry and motor function in Huntington's disease. J Huntingtons Dis. PMID: 30584176
Zuccato C, Valenza M, Cattaneo E. (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev. PMID: 20664082